Magnetic resonance imaging (MRI) allows for body composition assessment, including determination of fat-free muscle area (FFMA). This study aimed to evaluate the prognostic value of FFMA, opportunistically measured from pre-interventional liver MRI, to predict outcome in patients receiving radioembolization (RE) for treatment of hepatocellular carcinoma (HCC). Patients with high FFMA showed significantly increased overall survival following treatment. On multivariate analysis, FFMA was an independent predictor of survival and thereby may reveal additional prognostic information in these patients. FFMA may become a promising new biomarker, since it is easy to assess from routine clinical imaging and represents a potential therapeutic target.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords